Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Garcia-Aymerich, M. Benet, J.M. Antó, the PAC-COPD Research Group (Barcelona, Spain). Stability of COPD phenotypes over time. Eur Respir J 2012; 40: Suppl. 56, 4749

Member's Comments

No comment yet.

Related content which might interest you: COPD phenotypes Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2016 COPD phenotypes Source: International Congress 2015 – PG2 Asthma and COPD Year: 2015 SARS-CoV-2: Survival in COPD phenotypes Source: Virtual Congress 2021 – Emerging evidence on sub-acute and long COVID-19 Year: 2021 Relationships between stable state inflammation and time to exacerbation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006 Individual variation in the time course of symptoms during exercise in COPD Source: Annual Congress 2010 - Thoracic dynamics and dyspnoea on exercise Year: 2010 Heterogeneity and time course of asthma exacerbations: data from AUSTRI Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Overlapping phenotypes in asthma and COPD Source: Annual Congress 2010 - Similarities and differences between asthma and COPD: the "Dutch Hypothesis" revisited Year: 2010 Characterization of asthmatics displaying the functional phenotype of COPD Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT Source: International Congress 2014 – Markers Year: 2014 Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008 Stability of the eosinophilic phenotype in stable and exacerbated COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Prediction models for exacerbations in different COPD patient populations: Results of five large databases Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 COPD phenotypes and endotypes Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2018 The median number of COPD exacerbations per year in patients with different polymorphisms of the gene ADRB2 Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Using different pulmonary function parameters for establising reversibility in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 808s Year: 2006 A proposal of COPD phenotypes Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology Year: 2009 The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Stability of the exacerbation pattern defined by GOLD 2017 in a real-world COPD population Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017